Mutations and polymorphisms of the p21B transcript in breast cancer

International Journal of Cancer

Volumn 121, Issue 4, 2007, Pages 908-910

  Knappskog, Stian ^a,b   Chrisanthar, Ranjan ^a,b   Staalesen, Vidar ^a,b   Børresen Dale, Anne Lise ^c,d   Gram, Inger Torhild ^e   Lillehaug, Johan Richard ^a   Lønning, Per Eystein ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Breast cancer; p21; p21B; Polymorphism

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PACLITAXEL; PROTEIN P21; PROTEIN P21B; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; MUTATION; POLYMORPHISM, GENETIC;

EID: 34547097249     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22777     Document Type: Article

References (25)

1. Nozell S, Chen X. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene 2002;21:1285-94.
2. Ibrahim SO, Lillehaug JR, Dolphine O, Johnson NW, Warnakulasuriya K, Vasstrand EN. Mutations of the cell cycle arrest gene p21(WAF1), but not the metastasis-inducing gene S100A4, are frequent in oral squamous cell carcinomas from Sudanese toombak dippers and non-snuff-dippers from the Sudan, Scandinavia, USA and UK. Anticancer Res 2002;22:1445-51.
3. Park YE, Choi KC, Choi YH. p21 expression and mutation in gastric carcinoma: analysis by immunohistochemistry and PCR-SSCP. J Korean Med Sci 1998;13:507-12.
4. Qari MH, Khalil SH, Kambouris M, Meyer BF. Mutation of p16, p21 or cyclin dependent kinase 4 is rare in acute lymphoblastic leukaemia. Br J Haematol 1998;103:467-72.
5. Shiohara M, Koike K, Komiyama A, Koeffler HP. P21(WAF1) mutations and human malignancies. Leuk Lymphoma 1997;26:35-41.
6. Sun Y, Hildesheim A, Li H, Li Y, Chen JY, Cheng YJ, Hayes RB, Rothman N, Bi WF, Cao Y, Yao KT, Lanier AP, Hegamyer G, El-Deiry WS, Xiong Y, Colburn NH. No point mutation but a codon 31ser->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prev 1995;4:261-7.
7. Tsumanuma I, Tanaka R, Abe S, Kawasaki T, Washiyama K, Kumanishi T. Infrequent mutation of Waf1/p21 gene, a CDK inhibitor gene, in brain tumors. Neurol Med Chir (Tokyo) 1997;37:150-6 (discussion 6-7).
8. Chen WC, Wu HC, Hsu CD, Chen HY, Tsai FJ. p21 gene codon 31 polymorphism is associated with bladder cancer. Urol Oncol 2002; 7:63-6.
9. Facher EA, Becich MJ, Deka A, Law JC. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene. Cancer 1997; 79:2424-9.
10. Harima Y, Sawada S, Nagata K, Sougawa M, Ostapenko V, Ohnishi T. Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. Int J Mol Med 2001;7:261-4.
11. Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD, Lin CC. p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. J Clin Lab Anal 2001;15:184-7.
12. Ressiniotis T, Griffiths PG, Keers SM, Chinnery PF, Birch M. A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians. BMC Ophthalmol 2005;5:5.
13. Roh J, Kim M, Kim J, Park N, Song Y, Kang S, Lee H. Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett 2001;165:59-62.
14. Sjalander A, Birgander R, Rannug A, Alexandrie AK, Tornling G, Beckman G. Association between the p21 codon 31 A1 (arg) allele and lung cancer. Hum Hered 1996;46:221-5.
15. Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:174-5.
16. Tsai MH, Chen WC, Tsai FJ. Correlation of p21 gene codon 31 polymorphism and TNF-α gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal 2002;16:146-50.
17. Staalesen V, Leirvaag B, Lillehaug JR, Lonning PE. Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancer. Clin Cancer Res 2004;10:3438-43.
18. Staalesen V, Knappskog S, Chrisanthar R, Nordgard SH, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Gram IT, Kristensen VN, Borresen-Dale AL, Lillehaug JR, Lonning PE. The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer. Clin Cancer Res 2006;12:6000-4.
19. Geisler S, Borresen-Dale AL, Johnsen H, Aas T, Geisler J, Akslen LA, Anker G, Lonning PE. TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. Clin Cancer Res 2003;9:5582-8.
20. Geisler S, Lonning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Borresen-Dale AL. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res 2001;61: 2505-12.
21. Helle SI, Ekse D, Holly JMP, Lonning PE. The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids. J Steroid Biochem Mol Biol 2002;81:95-102.
22. Gram IT, Bremnes Y, Ursin G, Maskarinec G, Bjurstam N, Lund E. Percentage density, Wolfe's and Tabar's mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Res 2005;7:R854-R861.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
24. Terry LA, Boyd J, Alcorta D, Lyon T, Solomon G, Hannon G, Berchuck A, Beach D, Barrett JC. Mutational analysis of the p21/ WAF1/CIP1/SDI1 coding region in human tumor cell lines. Mol Carcinog 1996;16:221-8.
25. Shih CM, Lin PT, Wang HC, Huang WC, Wang YC. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn J Cancer Res 2000;91:9-15.